Skip to main content
. 2020 Aug 27;17(3):e386–e396. doi: 10.1200/OP.20.00118

FIG 2.

FIG 2.

Compliance and number of completions per participant for PRO-CTCAE (Patient Reported Outcomes version of the Common Terminology Criteria for Adverse Events) and EORTC (European Organization for Research and Treatment of Cancer QLQ-C30) questionnaires. (A) PRO-CTCAE weekly compliance across the 12-week study period. (B) EORTC compliance every 4 weeks across the 12-week study period. (C) Total number of PRO-CTCAE completions per participant. (D) Total number of EORTC completions per participant.